Greg Piefer

Oncology

Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.

News

RQ Bio has raised $115m for clinical trials of RQB01, a one-shot antibody designed for strain-agnostic protection against seasonal influenza viruses.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.